ARS-COV-2 lethality rate in Colombia: years 2020 y 2021

Letalidad por SARS-CoV-2 en Colombia años 2020 y 2021

Introduction: This pandemic poses the need to understand how to survive infections and why treatment may be heterogenous. Objective: to review the COVID-19 case fatality rate in Colombia between March 6, 2020 and December 31, 2021. Methodology: a cross-sectional study. Data was obtained from the Ministry of Health and Social Protection website based on the COVID – 19 vaccination plan. Results: COVID-19 case fatality rates were established by months in 2020 and 2021 in Colombia. It was observed that for the abovementioned period, the month with the highest case fatality rate was February 2021 with 3.69% and the lowest was December 2021 with 1.61%. Conclusion: the records of lethality and mortality rates enable monitoring the pandemic but are biased due to delays in confirming SAR-CoV2 infection and delays in reporting.

1. Wang J, Yin-Chi C, Niu R, Wong E, Van Wyk M. Modeling the Impact of Vaccination on COVID-19 and its Delta Variant. Research Square. 2021. https://doi.org/10.21203/rs.3.rs-1171015/v1
2. Belongia EA, Osterholm MT. COVID-19 and flu, a perfect storm. Science. 2020;368(6496):1163. doi: 10.1126/science.abd2220
3. Wigginton NS. Cunningham RM, Katz RH, Lidstrom M, Moler KA, Wirtz D, Zuber MT. Moving academic research forward during COVID-19. Science. 2020;368(6496):1190-1192. doi: 10.1126/science.abc5599
4. Jeong H, Rogers J, Xu S. Continuous on-body sensing for the COVID-19 pandemic: Gaps and opportunities. Sci Adv. 2020;6(36):eabd4794. doi: 10.1126/sciadv.abd4794
5. Singer BD. COVID-19 and the next influenza season. Sci Adv. 2020;6(31):eabd0086. doi: 10.1126/sciadv.abd0086
6. Ayres JS. Surviving COVID-19: A disease tolerance perspective. Sci Adv. 2020;6(18):eabc1518. doi: 10.1126/sciadv.abc1518
7. Kupferschmidt K, Cohen J. Race to find COVID-19 treatments accelerates. Science. 2020;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412
8. Ayres JS. The Biology of Physiological Health. Cell. 2020;181(2):250-269. https://doi.org/10.1016/j.cell.2020.03.036
9. Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, et al. Development of an inactivated vaccine candidate for SARS -CoV-2. Science. 2020;369(6499):77-81. doi: 10.1126/science.abc1932
10. World Health Organization. Coronavirus Disease (COVID-19) Dashboard [Internet]. 2021 [Consultado 25 de julio de 2021]. Disponible en: https://covid19.who.int/
11. Moreno-Altamirano A, López-Moreno S, Corcho-Berdugo A. Principales medidas en epidemiología [Internet]. 2017 [Citado 25 de julio de 2020]. Disponible en: https://www.scielosp.org/article/spm/2000.v42n4/337-348/es/
12. Quintana-Salgado L. Medidas de frecuencia en epidemiología [Internet]. 2015 [Citado 25 de julio de 2020]. Disponible en: https://es.slideshare.net/lualberts20/medidas-de-frecuencia-en-epidemiologa-2015
13. Díaz Pinzón JE. Descripción estadística del COVID- 19 según el grupo etario en Colombia. Repert Med Cir. 2020;29(Núm. Supl. 1):79–85. https://doi.org/10.31260/RepertMedCir.01217372.1098
14. Díaz Pinzón JE. Continuidad con los procesos pedagógicos de los estudiantes durante la pandemia ocasionada por el COVID-19. Repert Med Cir. 2020;29(Núm. Supl. 1):108–112. https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1128
15. Díaz Pinzón, J. E. (2020). Positividad y proporción para muestras por COVID-19 en Colombia. 2020;29(Núm. Supl. 1):127–130. https://doi.org/10.31260/RepertMedCir.01217372.1134
16. Instituto Nacional de Salud. Coronavirus (COVID-19) en Colombia [Internet]. 2022 (Consultado Ene 2022). Disponible en: https://www.ins.gov.co/Paginas/Inicio.aspx
17. Ward S, Lindsley A, Courter J, Assa A. Clinical testing for COVID-19. J Allergy Clin Inmunol. 2020;146(1):23–34. https://doi.org/10.1016/j.jaci.2020.05.012
18. Bravo L, Grillo-Ardila E. Análisis de mortalidad por COVID-19 en Colombia: Medidas de ocurrencia. Univ Salud. 2020;22(3):292-298. https://doi.org/10.22267/rus.202203.202